← Back to headlines
Matinas BioPharma Receives Notice from NYSE
Matinas BioPharma has announced that it received a notice from the New York Stock Exchange regarding a compliance matter.
3 Apr, 21:20 — 3 Apr, 21:20
Sources
Showing 1 of 1 sources
Related Stories
Trump's Proposed Budget Seeks Record $1.5 Trillion for Defense
17m ago
German Government Discusses Measures Against High Fuel Prices
20m ago
Yum Cha's Reinvention: Melody Tan Modernizes Family Dim Sum Business
45m ago
Mexico's Highest Housing Prices Identified in Mexico City, Baja California Sur, and Querétaro
48m ago